AzTrials
AzTrials

Pneumothorax At Trauma PatientsNCT06699277

Chest Ultrasound Versus Chest X-ray with Ct As Gold Standard At Trauma Patients

An observational study of Pneumothorax At Trauma Patients, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the predictive value of the chest ultrasound in detection of pneumothorax at chest trauma patients. The main question it aims to answer is: How does the performance of the chest ultrasound compare to chest X-ray in predicting pneumothorax in chest trauma patients… Read more about this study

Who is it for?
Any age
Conditions the study is for
Pneumothorax At Trauma Patients
How many people
100 participants
Where
No sites listed yet
Study dates
1 Jan 2025to 1 Mar 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Blunt chest trauma patients admitted to emergency departments in Assuit and Suez Canal University Hospitals.

Who may be able to join

  • patients with different ages.
  • both genders.
  • Patients presenting with isolated blunt chest trauma.
  • Patients who are hemodynamically stable and can undergo imaging studies (Ultrasonography, CXR, and CT).
  • Patients who provide informed consent (or proxy consent if the patient incapacitated).

Who cannot join

  • Hemodynamically unstable patients requiring immediate surgical intervention.
  • Patients with contraindications to CT imaging (e.g., severe renal impairment without access to alternative contrast agents).
  • Pregnant patients (due to radiation exposure from CT).
  • Patients with previous thoracic surgery or pre-existing significant thoracic abnormalities that could interfere with imaging interpretation.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Omar Elmokhtar Abdelaziz Ali, MBBCH contact

+201023236802

Omar.16266404@med.aun.edu.eg

Shaimaa Abbas Hassan, MD contact

+201002953253

shimaa.abbas@med.aun.edu.eg

About this study

Official title: Diagnostic Accuracy of Chest Ultrasonography Vs. Chest X-ray in the Evaluation of Chest Trauma: a Comparative Study Using CT As the Gold Standard.

The goal of this observational study is to learn about the predictive value of the chest ultrasound in detection of pneumothorax at chest trauma patients.

The main question it aims to answer is:

How does the performance of the chest ultrasound compare to chest X-ray in predicting pneumothorax in chest trauma patients in Egypt? Participants are patients with different ages Isolated blunt chest trauma patients admitted to the emergency department during the study period.

Read the detailed description

Chest trauma is a leading cause of morbidity and mortality, with timely and accurate diagnosis essential for effective treatment. While chest X-ray (CXR) has traditionally been the first-line imaging modality in emergency settings due to its availability and ease of use, it has limitations, particularly in detecting subtle or occult injuries like pneumothorax, haemothorax, rib fractures, and pulmonary contusions, especially in trauma patients positioned supine. Overuse of CXR can also lead to increased costs, radiation exposure, and emergency department overcrowding.

Ultrasound has emerged as an alternative, with multiple studies showing that chest ultrasonography (CUS) is highly sensitive and specific for detecting traumatic intrathoracic injuries, including pneumothorax. This systematic review and meta-analysis aimed to assess the diagnostic accuracy of CUS compared to CXR. While CT scans remain the gold standard for diagnosing thoracic trauma due to their superior accuracy, they expose patients to significant radiation and should be used judiciously. Although CXR is a fast and accessible option in emergencies, it may miss critical injuries, highlighting the importance of balancing diagnostic accuracy with patient safety and resource management in trauma care.

The primary aim of this study is to evaluate and compare the diagnostic accuracy of chest ultrasonography (sonar) versus chest X-ray (CXR) in the detection of thoracic injuries in patients presenting with chest trauma, using computed tomography (CT) as the reference standard.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic accuracy of chest ultrasonography compared to chest X-ray in the Evaluation of Chest Trauma patients.

    To evaluate and compare the diagnostic accuracy of chest ultrasonography (sonar) versus chest X-ray (CXR) in the detection of thoracic injuries in patients presenting with chest trauma, using computed tomography (CT) as the reference standard.

    Measured: Hour 3 after patient arrival to ER.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2024
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06699277
Sponsor's protocol ID
Chest ultrasound vs X-ray
Status last verified
Nov 2024
First submitted
19 Nov 2024
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pneumothorax At Trauma Patients, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Omar Elmokhtar Abdelaziz Ali, MBBCH (+201023236802, Omar.16266404@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic accuracy of chest ultrasonography compared to chest X-ray in the Evaluation of Chest Trauma patients. (time frame: Hour 3 after patient arrival to ER.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in